Clinical Trial Update: Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers [Phase 3]

View source ↗

Summary

A Phase 3 safety study of an ophthalmic solution for allergic conjunctivitis completed in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Snippet

Sponsor: Vistakon Pharmaceuticals | Conditions: Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis | Phase 3 | Status: COMPLETED